INTERNATIONAL PATENT: CARDIFF ONCOLOGY, INC. FILES APPLICATION FOR "USE OF PLK1 INHIBITOR IN COMBINATION OF GEMCITABINE OR CARBOPLATIN IN TREATING OVARIAN CARCINOMA"

GENEVA, Sept. 17 -- CARDIFF ONCOLOGY, INC. (11055 Flintkote AvenueSan Diego, California 92121) filed a patent application (PCT/US2025/018236) for "USE OF PLK1 INHIBITOR IN COMBINATION OF GEMCITABINE OR CARBOPLATIN IN TREATING OVARIAN CARCINOMA" on Mar 03, 2025. With publication no. WO/2025/188680, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RIDINGER, Maya (11055 Flintkote AvenueSan Diego, California 92121), SMEAL, Tod (11055 Flintkote AvenueSan Diego, California 92121)

Abstract: Provided include methods, compositio...